Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer

Maass N, et al. Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer. Clinical Trial 2014; 87(5):300-10. doi:10.1159/000365553. Epub 2014 Aug 26